| Schuchter, L M; Luginbuhl, W E; Meropol, N J (1992) The current status of toxicity protectants in cancer therapy. Semin Oncol 19:742-51 |
| Meropol, N J; Altmann, S W; Shanafelt, A B et al. (1992) Requirement of hydrophilic amino-terminal residues for granulocyte-macrophage colony-stimulating factor bioactivity and receptor binding. J Biol Chem 267:14266-9 |
| Meropol, N J; Hicks, D; Brooks, J J et al. (1992) Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome. Am J Hematol 40:126-34 |
| Meropol, N J; Miller, L L; Korn, E L et al. (1992) Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst 84:1201-3 |
| Meropol, N J; Kreider, B L; Lee, V M et al. (1991) A neutralizing monoclonal antibody binds to an epitope near the amino terminus of murine granulocyte-macrophage colony-stimulating factor. Hybridoma 10:433-47 |
